Thirty-four drugs, including some anti-infectives such as Ivermectin, Mupirocin and Nicotine Replacement Therapy, have been added to the National List of Essential Medicines taking the total drugs under it to 384.
Several antibiotics, vaccines and anti-cancer drugs will become more affordable by their addition to the list.
However, 26 drugs such as Ranitidine, Sucralfate, white petrolatum, Atenolol and Methyldopa have been deleted from the revised list.
The deletion has been done based on the parameters of cost effectiveness and availability of better drugs.
Union Health Minister Mansukh Mandaviya, who released the list today, tweeted, “Released the National List of Essential Medicines 2022.It comprises 384 drugs across 27 categories. Several antibiotics, vaccines, anti-cancer drugs and many other important drugs will become more affordable & reduce patients’ out-of-pocket expenditure.”
Endocrine medicines and contraceptives Fludrocortisone, Ormeloxifene, Insulin Glargine and Teneliglitin have been added to the list.
Montelukast, which acts on the respiratory track, and ophthalmological drug Latanoprost figure in the list. Cardiovascular medicines Dabigatran and Tenecteplase also find place in the list besides medicines used in palliative care.
“Antinfectives such as Ivermectine, Meropenem, Cefuroxime, Amikacin, Bedaquiline, Delamanid, Itraconazole ABC Dolutegravir have been added to the NLM,” Dr YK Gupta, Vice Chairman of the Standing National Committee on Medicines, said.
The drugs in NLEM are included in scheduled category and their price is regulated by the National Pharmaceutical Pricing Authority, Dr Gupta said.
A revised list of 399 formulations was submitted by an expert committee under the Indian Council of Medical Research (ICMR) last year. After detailed analysis of Indian requirements, major changes were sought by Mr Mandaviya.
(If you like reading The Outlooker, please consider subscribing to us below. Subscriptions are free for first 500 subscribers.)